Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Amy Kovacik
Effect of Galcanezumab Following Treatment Cessation in Patients With Migraine: Results From 2 Randomized Phase 3 Trials
Headache
Neurology
Related publications
Effects of Galcanezumab on Healthcare Resource Utilization and Acute Medication Use in Patients With Migraine: Results From Two Global Phase 3 Clinical Trials
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies
Headache
Neurology
Different Doses of Galcanezumab Versus Placebo in Patients With Migraine and Cluster Headache: A Meta-Analysis of Randomized Controlled Trials
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Efficacy and Safety of Lasmiditan in Patients Using Concomitant Migraine Preventive Medications: Findings From SAMURAI and SPARTAN, Two Randomized Phase 3 Trials
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
MRI Analysis From Two Phase 3 Randomized Clinical Trials; Treatment of Symptomatic Knee Osteoarthritis With Oral Salmon Calcitonin
Osteoarthritis and Cartilage
Sports Medicine
Rheumatology
Orthopedics
Biomedical Engineering
Improved Health-Related Quality of Life and Physical Function in Patients With Refractory Chronic Gout Following Treatment With Pegloticase: Evidence From Phase III Randomized Controlled Trials
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Neuropsychiatric Safety With Liraglutide 3.0 Mg for Weight Management: Results From Randomized Controlled Phase 2 and 3a Trials
Diabetes, Obesity and Metabolism
Internal Medicine
Endocrinology
Metabolism
Diabetes
PWE-167 Effect of Linaclotide on Ibs-Qol Sexual Subscale Scores in Patients With Irritable Bowel Syndrome With Constipation: Results From 2 Phase 3 Trials: Abstract PWE-167 Table 1
Gut
Gastroenterology
MDMA-assisted Psychotherapy for Treatment of PTSD: Study Design and Rationale for Phase 3 Trials Based on Pooled Analysis of Six Phase 2 Randomized Controlled Trials
Psychopharmacology
Pharmacology
